- Fluad(R)-MF59(R)-Adjuvanted Influenza Vaccine in Older Adults
-
Tsai TF
- KMID: 2284997
- Infect Chemother.
- 2013 Jun;45(2):159-174.
- doi: 10.3947/ic.2013.45.2.159
Influenza directly or indirectly contributes to the four leading causes of global mortality, at rates that are highest in older adults. As the proportion of older adults in the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Meningococcal Disease and Quadrivalent MenACWY-CRM Vaccine (Menveo(R))
-
Tsai TF
- KMID: 1430611
- Korean J Pediatr Infect Dis.
- 2012 Dec;19(3):89-110.
Meningococcal Disease, manifesting as meningitis and septicemia, is a life-threatening bacterial infection that results in significant morbidity and mortality, particularly in childhood. Its epidemic potential and limited opportunities for clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune Response to SA14-14-2 Live Attenuated Japanese Encephalitis Vaccine
-
Park MS, Rho HO, Sohn YM, Chandler L, Shope R, Tsai TF
- KMID: 2335472
- J Korean Pediatr Soc.
- 2000 Mar;43(3):351-359.
PURPOSE: SA14-14-2 live attenuated Japanese encephalitis (JE) vaccine has been administered safely and effectively to more than 100 million children in China since 1988, and recently licensure of the vaccine... -
- CITED
-
- Close
- SHARE
-
- Close
- The MARCOPOLO Study of Ustekinumab Utilization and Efficacy in a Real-World Setting: Treatment of Patients with Plaque Psoriasis in Asia-Pacific Countries
-
Youn SW, Tsai TF, Theng C, Choon SE, Wiryadi BE, Pires A, Tan W, Lee MG, MARCOPOLO Investigators
- KMID: 2171381
- Ann Dermatol.
- 2016 Apr;28(2):222-231.
- doi: 10.5021/ad.2016.28.2.222
BACKGROUND: Ustekinumab is a fully human monoclonal antibody approved for the treatment of chronic moderate-to-severe plaque psoriasis in adults. However, factors including efficacy, tolerability, ease of use, and cost burden... -
- CITED
-
- Close
- SHARE
-
- Close
